Sippel, Anna
Riemann-Lorenz, Karin
Pöttgen, Jana
Wiedemann, Renate
Drixler, Karin
Bitzer, Eva Maria
Holmberg, Christine
Lezius, Susanne
Heesen, Christoph
Funding for this research was provided by:
Roche Pharma AG
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 11 April 2022
Accepted: 11 August 2022
First Online: 16 August 2022
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Hamburg Chamber of Physicians (protocol code PV5770, date of approval 22/05/2018). Informed consent was obtained from all subjects.
: Not applicable.
: A.S. has received funding from Roche Pharma and salaries for talks from Novartis. C.H. has received research grants, congress travel compensations and salaries for talks from Biogen, Genzyme, Sanofi-Aventis, Bayer Healthcare, Merck, Teva Pharma, Roche Pharma, and Novartis. K.R-L., J.P., R.W., C.H., K.D., E.M.B., and S.L. declare that they have no competing interests.